FDA lifts clinical hold on Atara’s lead treatment
Thousand Oaks-based Atara Biotherapeutics received a bit of good news on May 5, after the U.S. Food and Drug Administration announced that it has lifted its hold on Atara’s active Investigational New Drug application for the Ebvallo program. Ebvallo, which is already approved in Europe and is used for transplant-related blood cancer, was placed on Read More →

Dubroff: It’s been a tough slog from First Republic to 2025
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Teledyne delivers Q1 earnings beat, announces new CEO
Thousand Oaks-based Teledyne Technologies has had an interesting end to the month of April, beating analysts’ expectations when it released its earnings on April 23 and announcing its new CEO a few days later on April 28. George C. Bobb III, who most recently served as the company’s president and COO, was elevated to president Read More →
Teledyne appoints new CEO
Thousand Oaks-based Teledyne Technologies has a new chief executive, the company announced April 28. George C. Bobb III, who most recently served as the company’s president and COO, was elevated to president and CEO effective immediately, the company said after the markets closed April 28. Bobb takes over for Edwin Roks, who retired from the Read More →
Energy Vault faces delisting from the NYSE
Westlake Village-based Energy Vault, a global energy storage company, received a notice from the New York Stock Exchange on April 16 that the company is not in compliance with NYSE’s continued listing standards. This is because the average closing price of Energy Vault’s common stock was less than $1 over a consecutive 30-trading-day period. Shares Read More →








